Cti Biopharma Corp buy Needham & Company LLC
Start price
06.03.23
/
50%
€4.56
Target price
06.03.24
€8.42
Performance (%)
83.36%
End price
07.03.24
-
Summary
This prediction is currently being closed. With a performance of 83.36% the BUY prediction by Needham___Company_LL is a big success. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cti Biopharma Corp | - | - | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% |
Comments by Needham___Company_LL for this prediction
In the thread Cti Biopharma Corp diskutieren
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
In the thread Trading Cti Biopharma Corp
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten